Norethindrone for Perimenopause: What It Treats, What It Doesn't, and Which One You're On

The HRT Index Editorial TeamIndependent women's health research

Last reviewed:August 28, 2026

Editorial research — not medically reviewed by a clinician. Why this label

Last updated: August 28, 2026 · Last verified: August 28, 2026 · By The HRT Index Editorial Team. Educational research, not medical advice, and not reviewed by a clinician. See our medical review policy. Full disclosure.

Need help choosing your next care step?

This page is a medication decoder, not a dose-conversion guide. If you are unsure whether your prescription is intended for contraception, bleeding, or menopause hormone therapy, use the free path tool to organize your questions before a licensed clinician visit.

Use Find My HRT Path

Affiliate disclosure: We may earn a commission from some links on this page. It never changes what we verify or what we publish. How our affiliate model works.

Norethindrone for perimenopause is not one treatment. The six commonly confused formulation families include a 0.35 mg contraceptive, a 5 mg tablet labeled for certain evaluated bleeding conditions, and fixed estrogen–norethindrone menopause therapies. They are not interchangeable, and unexplained bleeding needs evaluation before a medication label can explain it.^[1]^[2]^[3]^[4]^[5]^[6]

That last distinction is the one that surprises most women. It is why someone can ask for help with hot flashes, receive a pill called norethindrone, and conclude that “hormones did nothing” — when the prescription may have been built for contraception or bleeding instead.

Here is the part nobody tells you clearly enough: the word “norethindrone” does not identify the job of the product. The active ingredients, strength, form, and regimen do.

Is this page for you?

Best for	Not for you if
You were prescribed norethindrone and want to know what it is supposed to do	You are bleeding heavily right now — use the urgent-care box below
You are not sure whether you received birth control, a bleeding treatment, or menopause hormone therapy	Your bleeding is new, persistent, after sex, or has not been evaluated — arrange clinical assessment
You are deciding whether to ask for a different formulation	You want a dose to copy — these products cannot be converted milligram for milligram
You want to walk into your next appointment with the right question	You want a provider ranking rather than a medication decoder — use our best online HRT providers comparison

⚠️ Read this first
Get emergency care if you are changing pads or tampons every hour for more than two hours in a row and you also have chest pain, shortness of breath, lightheadedness, or dizziness. ACOG uses that combination as an emergency threshold for abnormal uterine bleeding.^[7]
Arrange prompt evaluation for bleeding between periods, bleeding after sex, persistent or unusually heavy bleeding, or any bleeding after 12 full months without a natural period. Those patterns should not be dismissed as “just perimenopause.”^[8]^[9]

Which norethindrone product am I probably looking at? The 30-second version

What the label says	What it usually is	The catch
Norethindrone 0.35 mg	Progestin-only contraception — the traditional “mini-pill”	No estrogen is listed as an active ingredient. It is not FDA-approved as menopause hormone therapy.
Norethindrone acetate 5 mg	Treatment for secondary amenorrhea, endometriosis, or certain evaluated abnormal bleeding	It is not FDA-approved as contraception. Its standalone label is not approved for use with estrogen in postmenopausal women for endometrial protection.
Estradiol + norethindrone acetate tablet or patch	Fixed-combination menopause hormone therapy	It contains systemic estrogen and is not labeled as contraception.
Norethindrone acetate + ethinyl estradiol	Either menopause hormone therapy or combined contraception, depending on the exact strength and pack	The ingredient names alone do not tell you which one you have.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

What does norethindrone actually do in perimenopause?

Norethindrone is a synthetic progestin. In perimenopause, a norethindrone-containing product may be used for pregnancy prevention, certain evaluated bleeding problems, or as the progestin component of a fixed estrogen-containing menopause therapy. No norethindrone-only U.S. product is FDA-approved for hot flashes or night sweats.^[1]^[2]^[3]^[4]^[5]^[6]

Let's slow down on the word progestin. Progesterone is a hormone the ovaries produce. A progestin is a synthetic drug that acts through progesterone-related pathways. They can serve overlapping clinical jobs, but they are not the same drug and their numbers do not convert.

The three jobs

Job one: contraception. The traditional 0.35 mg norethindrone tablet is FDA-approved to prevent pregnancy. Pregnancy remains possible in perimenopause, even when cycles are irregular. This pill may change bleeding too, but irregular bleeding is also its most frequently reported adverse effect.^[1]^[10]

Job two: treatment of certain bleeding conditions. Standalone norethindrone acetate 5 mg is FDA-approved for secondary amenorrhea, endometriosis, and abnormal uterine bleeding caused by hormonal imbalance when organic pathology has not been identified. It has no contraceptive indication.^[2]

Job three: one component of fixed menopause hormone therapy. FDA-approved products pair estradiol or ethinyl estradiol with norethindrone acetate in a specific tablet or patch. Those products have their own indications, strengths, trials, contraindications, and bleeding expectations.^[3]^[4]^[5]

Same drug family. Three completely different reasons to be holding it.

The damaging admission most pages skip

Norethindrone is not a one-size-fits-all perimenopause treatment. If your main problem is hot flashes, a norethindrone-only pill is not equivalent to a product that contains systemic estrogen. If your main problem is preventing pregnancy, a 5 mg norethindrone acetate tablet is not an FDA-approved contraceptive. If your bleeding has not been evaluated, a prescription cannot tell you what caused it.

That limitation is exactly why the medicine becomes easier to judge once its job is named. The useful question is not “Is norethindrone good for perimenopause?” It is:

Which norethindrone product is this, what job was it chosen to do, and does that job match the reason I sought care?

Why “Which brand?” is the wrong first question

Brand availability and packaging can change. The more reliable fingerprint is:

1. Every active ingredient
2. Every strength and unit
3. Tablet, patch, or another dosage form
4. The pack and schedule printed on the dispensing label

If the pharmacy label and patient portal disagree, do not pick the one you prefer. Ask the pharmacist to reconcile them.

Which norethindrone prescription do I actually have?

Identify the product from every active ingredient, strength, and dosage form. A 0.35 mg norethindrone tablet without an estrogen ingredient is a contraceptive; a 5 mg norethindrone acetate tablet has different labeled uses; and products listing estradiol or ethinyl estradiol belong to separate menopause-therapy or contraceptive categories.^[1]^[2]^[3]^[4]^[5]^[6]

Four steps, one minute

Step 1 — Find every active ingredient. Check the pharmacy label, blister foil, carton, and patient leaflet. A portal entry may be abbreviated, so ask the pharmacist about any mismatch.

Step 2 — Read every strength, including the units. mg and mcg are not interchangeable. If two ingredients appear, record both numbers.

Step 3 — Check whether an estrogen is listed. Look for estradiol or ethinyl estradiol. A standalone norethindrone or norethindrone acetate product has no estrogen listed as an active ingredient.

Step 4 — Look at the form and pack. One tablet every day without placebo pills, a 24/4 contraceptive pack, a continuous menopause tablet, and a twice-weekly patch are different products even when “norethindrone” appears on each label.

The Norethindrone Prescription Decoder

We assembled six commonly confused U.S. label families into one table. It is a product-identity tool, not a dosing chart and not a complete list of every U.S. drug that contains norethindrone acetate.

What your label says	Form	Estrogen listed as an active ingredient?	FDA-labeled main job	FDA-approved as contraception?	Why it may appear in perimenopause care
Norethindrone 0.35 mg	Daily tablet, 28 active tablets	No	Prevent pregnancy	Yes	Contraception is still needed until menopause is confirmed; the pill may also change bleeding patterns
Norethindrone acetate 5 mg	Standalone tablet	No	Secondary amenorrhea, endometriosis, and abnormal uterine bleeding caused by hormonal imbalance in the absence of organic pathology	No	May be prescribed after evaluation for heavy or unpredictable bleeding
Estradiol 1 mg + norethindrone acetate 0.5 mg or estradiol 0.5 mg + NETA 0.1 mg	Daily fixed-combination tablet	Yes — estradiol	Menopause hormone therapy for labeled indications that include moderate-to-severe vasomotor symptoms; indications differ by strength	No	Provides systemic estrogen and a progestin in one product for an appropriate woman with a uterus
Estradiol + norethindrone acetate transdermal system	CombiPatch, changed twice weekly	Yes — estradiol	Fixed-combination menopause hormone therapy for labeled indications including moderate-to-severe vasomotor symptoms	No	Delivers systemic estrogen and NETA through one patch
Norethindrone acetate 1 mg + ethinyl estradiol 5 mcg	Jinteli-type continuous tablet	Yes — ethinyl estradiol	Moderate-to-severe vasomotor symptoms due to menopause and prevention of postmenopausal osteoporosis	No	A menopause product whose ingredient names resemble some contraceptive pills
Norethindrone acetate 1 mg + ethinyl estradiol 20 mcg	Junel Fe 24-type contraceptive pack	Yes — ethinyl estradiol	Prevent pregnancy	Yes	A combined contraceptive that may be considered for an eligible perimenopausal woman who still needs birth control

Source: current U.S. labeling for norethindrone 0.35 mg, norethindrone acetate 5 mg, oral estradiol/NETA, CombiPatch, Jinteli, and Junel Fe 24.^[1]^[2]^[3]^[4]^[5]^[6]

The comparison that proves the point

Two products can contain the same 1 mg of norethindrone acetate and still have different labeled purposes:

	Jinteli-type menopause product	Junel Fe 24-type contraceptive
Norethindrone acetate	1 mg	1 mg
Ethinyl estradiol	5 mcg	20 mcg
FDA-labeled purpose	Menopause vasomotor symptoms and osteoporosis prevention	Pregnancy prevention
Is it FDA-approved birth control?	No	Yes

Same progestin amount. Four times as much listed ethinyl estradiol in the contraceptive example. Two different product categories. The ingredient name alone cannot tell you what the prescription is for.^[5]^[6]

The rule that keeps you safe

Do not compare or convert these doses milligram for milligram.
Norethindrone 0.35 mg, norethindrone acetate 5 mg, low-dose NETA inside a fixed menopause product, and 100 or 200 mg micronized progesterone are not different sizes of one interchangeable medicine. Do not split, substitute, increase, or reduce them from an online conversion.

The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.

Found your formulation but not sure it fits your goal? Find My HRT Path turns your symptoms, medication route, uterus status, risk-history answers, insurance situation, and state into a plain-language care path.
→ Match my situation to the right care path
Health-data handling: Consumer Health Data Privacy Policy.

Is norethindrone for perimenopause birth control, HRT, or a bleeding treatment?

It can belong to any of those categories, but not as one interchangeable product. Norethindrone 0.35 mg is labeled for contraception; standalone norethindrone acetate 5 mg is labeled for amenorrhea, endometriosis, and certain abnormal bleeding; and specific estrogen–norethindrone combinations are labeled as menopause hormone therapy.^[1]^[2]^[3]^[4]^[5]^[6]

This is where most of the confusion — and most of the frustration — lives.

When it is birth control

The traditional 0.35 mg norethindrone pill contains no estrogen ingredient and is taken continuously without a placebo break. Its FDA-labeled purpose is pregnancy prevention.^[1]

One detail matters more than most people realize: the traditional norethindrone mini-pill has a three-hour missed-pill window. CDC guidance treats it as missed when it is more than three hours late. The current instruction is to take the missed pill as soon as possible, continue daily pills, and use condoms or avoid sex until pills have been taken correctly for two consecutive days. Emergency contraception may need consideration after unprotected sex.^[11]

Three hours. Not a day. If you have been treating it like another type of pill, check the exact missed-dose instructions tonight.

When it is a bleeding treatment

The standalone 5 mg norethindrone acetate label ties its abnormal-bleeding indication to hormonal imbalance after organic pathology has not been identified. In plain language, a medication can suppress bleeding without telling you whether a fibroid, polyp, pregnancy, cervical problem, endometrial abnormality, or another cause is present.^[2]

That is not a reason to distrust the prescription. It is a reason to know the answer to one question:

What did we evaluate before deciding this was hormonal bleeding?

When it is menopause hormone therapy

Oral estradiol/NETA products, CombiPatch, and Jinteli are fixed estrogen–progestin menopause therapies. The FDA reviewed those exact formulations, strengths, regimens, and trial data.^[3]^[4]^[5]

You cannot recreate one of them by mentally pairing any estradiol patch with any norethindrone tablet. Clinicians may prescribe separate components, but that is a clinician-directed regimen — not an equivalence the label lets a reader assume.

What “off-label” actually means

Off-label does not mean illegal or automatically inappropriate. It means FDA has not approved that exact drug, dose, route, or formulation for that exact use. FDA has therefore not determined that the product is safe and effective for that specific unapproved use.^[12]

A useful explanation from the prescriber should name:

The clinical goal
Why this formulation was selected
What evidence supports the choice
What result is expected
What will be monitored
What would make the plan change

Can norethindrone help heavy or irregular perimenopause bleeding?

Norethindrone acetate can be prescribed for certain abnormal uterine bleeding, but the FDA-labeled 5 mg indication assumes the bleeding is caused by hormonal imbalance and that organic pathology has not been identified. The 0.35 mg contraceptive may alter bleeding, but it is not FDA-approved as a heavy-bleeding treatment.^[1]^[2]

What “absence of organic pathology” means in real life

A progestin cannot rule out:

Pregnancy
Fibroids
Endometrial polyps
Adenomyosis
Cervical disease
Endometrial hyperplasia or cancer
Infection
A bleeding disorder
A medication-related cause

The exact evaluation depends on age, pattern, severity, pregnancy possibility, examination findings, and risk history. It can include pregnancy testing, a blood count, pelvic examination, ultrasound, or endometrial sampling.^[8]^[13]

Why age 45 changes the conversation

ACOG recommends endometrial tissue sampling as a first-line test for abnormal uterine bleeding in patients older than 45. Sampling can also be appropriate in younger patients when bleeding persists, medical treatment fails, or risk factors are present.^[13]

That does not mean bleeding after 45 is usually cancer. It means the threshold for looking at the endometrium changes enough that “it is probably perimenopause” is no longer a complete evaluation.

Define success before the first pill

Ask what the medicine is supposed to accomplish:

Fewer heavy days
Less total blood loss
Fewer unpredictable episodes
A planned withdrawal bleed
Suppression of bleeding
Endometriosis symptom control
A temporary bridge while an evaluation continues

A prescription without a defined goal is hard to judge. “Take this and see” is not the same as knowing what result should trigger continuation, adjustment, or a different workup.

Does norethindrone help hot flashes and night sweats?

No norethindrone-only U.S. product is FDA-approved for hot flashes or night sweats. Fixed products that combine estradiol or ethinyl estradiol with norethindrone acetate are FDA-approved for vasomotor symptoms, but those are estrogen-containing menopause therapies — not the 0.35 mg mini-pill or standalone 5 mg NETA tablet.^[1]^[2]^[3]^[4]^[5]

This section resolves a specific kind of quiet disappointment.

If you asked for help with hot flashes, night sweats, broken sleep, or brain fog, received a norethindrone-only tablet, and still feel the same months later, that does not prove that every form of hormone therapy failed you. It may mean that the prescription's primary job was contraception, bleeding control, or another goal.

Problem you want treated	What a norethindrone-only label supports
Preventing pregnancy	Yes — only the 0.35 mg contraceptive product
Certain evaluated abnormal bleeding	Yes — the standalone NETA 5 mg label
Endometriosis	Yes — the standalone NETA 5 mg label
Hot flashes or night sweats	No FDA-labeled indication for a norethindrone-only product
Brain fog, insomnia, or mood symptoms	No FDA-labeled indication
Vaginal dryness or painful sex	No FDA-labeled indication for a norethindrone-only product

The Menopause Society says hormone therapy is effective for bothersome hot flashes and night sweats during perimenopause. When contraception is also needed, continuous combined hormonal contraceptives are often used; another option is a levonorgestrel IUD plus estrogen therapy.^[10] For the broader risk-and-benefit decision, see HRT benefits, risks, and who it may fit.

If hot flashes are your main problem and you are on norethindrone alone, bring this sentence to the next appointment: “Which symptom is this prescription intended to treat?”

Is norethindrone the same as progesterone?

No. Norethindrone and norethindrone acetate are synthetic progestins. Micronized progesterone is a different prescription hormone with the same molecular structure as endogenous progesterone. They can fill overlapping roles, but they have different labels, formulations, evidence, and adverse-effect profiles, and their doses cannot be converted into one another.^[2]^[14]

The three words people mix up

Progesterone — the ovarian hormone and the generic name of FDA-approved micronized progesterone capsules.
Progestogen — the umbrella term for drugs or hormones with progesterone-like activity.
Progestin — the common term for synthetic progestogens such as norethindrone.

Norethindrone versus norethindrone acetate

Norethindrone acetate is rapidly converted to norethindrone after absorption. That biochemical relationship does not make the products interchangeable: strength, formulation, regimen, and indication still decide what the prescription is doing.^[2]

Why “Which is stronger?” is a dead-end question

The numbers are measuring different products, not a universal progesterone scale. A better comparison asks:

Question	Why it matters more than the milligram number
Is contraception needed?	Micronized progesterone and standalone NETA 5 mg are not FDA-approved contraceptives
Is systemic estrogen being used?	The progestogen plan must match the estrogen regimen and uterus status
Is the goal bleeding treatment, endometrial risk reduction, or symptom treatment?	Different goals use different products and evidence
What bleeding pattern is expected?	A cyclic regimen, continuous regimen, contraceptive POP, and fixed combination do not create the same pattern
What adverse effect is making you reconsider?	Tolerability may drive a clinically supervised switch without implying one drug is universally “better”

No dose-conversion rule: Do not turn 5 mg NETA into a guessed amount of micronized progesterone, or vice versa. If the current product is not a fit, ask for a deliberate substitution plan.

Is norethindrone for perimenopause FDA-approved?

Some exact products and uses are FDA-approved; “norethindrone for perimenopause” is not one FDA indication. The 0.35 mg product is approved for contraception, the 5 mg acetate tablet for specific conditions including certain abnormal bleeding, and fixed estrogen–NETA products for menopause indications. Standalone NETA 5 mg is not approved with estrogen for postmenopausal endometrial protection.^[1]^[2]^[3]^[4]^[5]

The standalone 5 mg label finding

The current U.S. label for norethindrone acetate 5 mg states:

“Norethindrone Acetate Tablets, USP are not intended, recommended or approved to be used with concomitant estrogen therapy in postmenopausal women for endometrial protection.”^[2]

The patient leaflet also directs postmenopausal women not to use that standalone product.

What that does — and does not — mean

1. It is not a verdict on your prescriber. A clinician may choose an off-label regimen when clinically appropriate. The label tells you that FDA did not approve this standalone product for that exact use.

2. It does not erase the evidence for fixed combinations. Estradiol/NETA tablets and CombiPatch are FDA-approved formulations in which NETA is part of the product studied for menopause treatment.^[3]^[4]

3. The dose gap is not a conversion instruction. The fixed oral menopause products contain 0.1 to 0.5 mg NETA; the standalone tablet contains 5 mg. That shows they are different products built for different labeled jobs. It does not tell a reader how to alter a prescription.

4. Perimenopause and postmenopause are not the same label population. The useful question is not “Should I stop?” It is: “What is our review trigger as I move from perimenopause into menopause?”

Why two hormone-therapy labels may look different in 2026

On February 12, 2026, FDA approved updated labeling for the first six menopausal hormone therapy products after requesting class-wide changes. The six were Prometrium, Divigel, Cenestin, Enjuvia, Estring, and Bijuva. The approved changes removed cardiovascular-disease, breast-cancer, and probable-dementia statements from the boxed warning for those products.^[15]^[16]

As of August 28, 2026, the current oral estradiol/NETA and CombiPatch labels we checked still displayed the earlier boxed-warning language.^[3]^[4]

That mismatch reflects the current product-by-product labeling status. It does not establish that one progestogen or one combination is safer than another. Read the current label for the exact product rather than borrowing a warning box from a different medicine.

Does norethindrone protect the uterine lining?

Norethindrone acetate reduced estrogen-induced endometrial hyperplasia when it was tested inside a specific fixed estradiol/NETA product. In a 12-month trial of 1,176 postmenopausal women, hyperplasia occurred in 14.6% of evaluable women taking estradiol alone versus 0.4% to 0.8% across the three estradiol-plus-NETA groups.^[3]

Endometrial hyperplasia is overgrowth of the uterine lining. It can be a precursor to endometrial cancer. That is why a woman with a uterus using systemic estrogen needs a deliberate endometrial-protection plan.

What the fixed-combination trial found

Randomized treatment arm	Evaluable women with endometrial hyperplasia after 12 months
Estradiol 1 mg alone	36 of 247 — 14.6%
Estradiol 1 mg + NETA 0.1 mg	2 of 249 — 0.8%
Estradiol 1 mg + NETA 0.25 mg	1 of 251 — 0.4%
Estradiol 1 mg + NETA 0.5 mg	1 of 241 — 0.4%

The trial enrolled postmenopausal women and studied those exact daily oral combinations.^[3]

Three things matter:

One: unopposed systemic estrogen produced a much higher hyperplasia rate in this trial. The progestogen plan is not a formality.

Two: all three NETA combination groups had observed rates below 1%. The equal 0.4% observations in the 0.25 mg and 0.5 mg groups do not prove those doses are universally equivalent or interchangeable.

Three: these data do not convert a standalone 5 mg tablet into an FDA-approved partner for any separate estradiol product. That remains a distinct, potentially off-label prescribing decision.

The one change not to make on your own
If you have a uterus and use systemic estrogen with a prescribed progestogen, do not stop, reduce, or replace the progestogen without the prescriber who manages the estrogen. If it is causing problems, that is a reason to revise the plan — not to leave systemic estrogen unopposed.

Can I take norethindrone with an estradiol patch?

A clinician may prescribe a progestogen with systemic estradiol for a woman with a uterus, and an FDA-approved estradiol/NETA combination patch exists. That does not make every norethindrone tablet an interchangeable partner for every estradiol patch. The exact drug, dose, schedule, bleeding plan, and reason for the pairing must be defined.^[4]

The FDA-approved fixed-patch example

CombiPatch delivers estradiol 0.05 mg per day with either NETA 0.14 mg per day or 0.25 mg per day and is applied twice weekly. It is a fixed product with its own indications, contraindications, and clinical data.^[4]

A separate patch plus a separate tablet is a different regimen

Separate-component prescribing can be clinically legitimate. But the existence of CombiPatch does not validate a guessed separate-tablet equivalent, and the standalone NETA 5 mg label does not provide an approved postmenopausal endometrial-protection regimen.^[2]^[4]

Ask four questions:

1. Is this an FDA-approved fixed combination or separate components?
2. What is the progestogen intended to accomplish?
3. What bleeding pattern should trigger reassessment?
4. When will the regimen be reviewed as I move through menopause?

Will norethindrone stop my period, or make bleeding worse first?

No norethindrone product can guarantee that periods will stop. In trials of fixed oral estradiol/NETA therapy in postmenopausal women, about 86% were amenorrheic after 12 months on 1 mg/0.5 mg and 88% after six months on 0.5 mg/0.1 mg. The 0.35 mg contraceptive can instead produce irregular, frequent, prolonged, or absent bleeding.^[1]^[3]

This is the section people search for at 2 a.m., so the product matters more than the promise.

On fixed oral estradiol/NETA menopause therapy

The current label says irregular bleeding or spotting occurred during the early months and generally declined over time. The 86% and 88% figures came from postmenopausal women using those exact fixed oral combinations — not from perimenopausal women taking standalone norethindrone.^[3]

In a separate placebo-controlled trial of the 0.5 mg estradiol/0.1 mg NETA tablet, treatment-emergent vaginal hemorrhage was reported by 26% of 194 women on treatment versus 12% of 200 women on placebo. “Treatment-emergent” does not prove causation for an individual, but the comparison shows why early bleeding deserves a place in the expectations conversation.^[17]

On the 0.35 mg mini-pill

Irregular bleeding is the most frequently reported adverse effect. Bleeding may become lighter, heavier, more frequent, less frequent, prolonged, or absent. There is no reliable way to promise which pattern an individual will get.^[1]

On the standalone 5 mg acetate tablet

The labeled regimen changes by indication. For abnormal bleeding or secondary amenorrhea, the label describes a limited course; for endometriosis, it describes a titrated longer regimen. Do not copy either schedule from an article — the prescriber should tell you which goal and schedule apply.^[2]

The four variables that change the answer

1. The exact product
2. Adherence and missed doses
3. The cause of the bleeding
4. Time since starting or changing treatment

A bleeding tracker is more useful than trying to remember whether “last week was bad.” Record the date, flow level, products used, clots, pelvic pain, dizziness, missed or late pills, and any new medication.

Not sure whether your bleeding pattern belongs with online care or an in-person evaluation?
→ Check the safest starting point for my situation
Find My HRT Path is not for emergencies and does not diagnose the cause of bleeding.

Does norethindrone acetate turn into estrogen?

Norethindrone acetate tablets do not list estrogen as an active ingredient. A small amount of NETA is metabolized to ethinyl estradiol; one FDA label estimates that 1 mg of NETA produces ethinyl-estradiol exposure comparable to 2.8 mcg taken orally. That pharmacokinetic fact does not turn NETA into an estrogen-containing product or create a dose-equivalence rule.^[18]

This is relevant because some women receive a progestin-only option specifically to avoid a listed estrogen ingredient.

What the number can tell you

Metabolism produces measurable ethinyl estradiol exposure.
The amount is dose-related.
A high therapeutic NETA dose is not pharmacologically identical to a 0.35 mg norethindrone contraceptive pill.

What the number cannot tell you

That 5 mg NETA is clinically equivalent to a combined birth-control pill
That it carries the same benefits or risks as a pill containing a listed ethinyl estradiol dose
That you should stop, split, or change the prescription
That a mathematical conversion can decide eligibility

A 2021 review concluded that the clinical implications deserve particular consideration at therapeutic norethisterone/NETA doses for women with elevated clot or breast-cancer risk, while also describing important evidence gaps.^[19]

If avoiding estrogen was the reason this product was chosen, say that out loud at the next appointment and ask whether the exact formulation and dose still fit that goal.

What are the side effects of norethindrone in perimenopause?

The side-effect profile depends on the product. Irregular bleeding is most prominent with norethindrone 0.35 mg; the standalone 5 mg NETA label lists headache, breast pain, bleeding changes, cramps or bloating, nausea or vomiting, and hair loss among common effects; estrogen-containing combinations have a separate warning and contraindication profile.^[1]^[2]^[3]^[4]^[5]^[6]

Do not mix side-effect lists across products

Product family	Label details that matter most
Norethindrone 0.35 mg contraceptive	Menstrual irregularity is most frequently reported; headache, breast tenderness, nausea, and dizziness increased in some studies; androgenic effects such as acne, excess hair, and weight gain are described as rare
Standalone NETA 5 mg	Common effects include headache, breast pain, irregular bleeding or spotting, abdominal cramps or bloating, nausea or vomiting, and hair loss; the label also lists weight changes, depression, mood swings, insomnia, lipid changes, and thrombotic events among reported adverse reactions
Fixed estradiol/NETA or NETA/ethinyl estradiol menopause therapy	Adds estrogen-related contraindications and warnings; use the current label for the exact oral or transdermal product
NETA/ethinyl estradiol contraceptive	Uses combined-hormonal-contraceptive warnings and missed-pill instructions, not the rules for the 0.35 mg mini-pill

Numbers with a comparison group

A placebo-controlled trial of the estradiol 0.5 mg/NETA 0.1 mg combination reported:^[17]

Treatment-emergent event	Fixed combination, n=194	Placebo, n=200
Vaginal hemorrhage	26%	12%
Headache	22%	19%
Nasopharyngitis	21%	18%
Endometrial thickening	10%	4%
Back pain	10%	4%
Diarrhea	6%	6%
Nausea	5%	4%

This table applies to that exact low-dose estrogen/NETA product and postmenopausal study population. It does not estimate the side-effect rate of standalone NETA 5 mg or the 0.35 mg mini-pill.

Weight change, honestly

Weight change appears in labeling for norethindrone-containing products, but no label supports promising a specific amount or predicting that every user will gain. The 0.35 mg contraceptive label describes androgenic effects including weight gain as rare; the standalone NETA label lists increases or decreases in weight among reported reactions.^[1]^[2]

We are not going to tell you “hormones never cause weight gain.” That is a slogan, not a product-specific answer. If weight changed meaningfully after starting, track timing and other changes and bring the pattern to the prescriber.

Mood symptoms deserve a direct question

The standalone NETA label lists clinical depression and mood swings and says women with a history of clinical depression should be observed carefully. A severe or concerning mood change deserves prompt contact with the treating clinician.^[2]

Estrogen changes the warning list

If the active ingredients include estradiol or ethinyl estradiol, the product has estrogen-related contraindications and warnings. These can involve unexplained genital bleeding, certain cancers, thromboembolic disease, stroke or myocardial infarction, liver disease, and other product-specific conditions.^[3]^[4]^[5]^[6]

Do not copy the warning box from one norethindrone product to another. Read the current label for the exact product in your hand.

Do I still need birth control during perimenopause?

Yes, if pregnancy is possible and you do not want one. Ovulation becomes unpredictable in perimenopause, not impossible. Norethindrone 0.35 mg is FDA-approved as contraception; standalone NETA 5 mg and fixed estradiol/NETA menopause products are not. Menopause hormone therapy should not be treated as birth control.^[1]^[2]^[3]^[4]^[10]

Question	Norethindrone 0.35 mg mini-pill	Fixed estrogen/NETA menopause therapy
FDA-approved to prevent pregnancy?	Yes	No
Contains a listed estrogen ingredient?	No	Yes
Uses the traditional three-hour missed-pill rule?	Yes	No — it is not a contraceptive regimen
Can ingredient names overlap with other product families?	Yes	Yes
Can one replace the other?	No	No

The Menopause Society advises contraception until menopause is confirmed one year after the final menstrual period. Hormonal contraception can mask or alter bleeding, so the timing of that transition may require a clinician-guided plan rather than a guess from one absent bleed.^[10]

When does perimenopause bleeding need in-person care?

Heavy bleeding with cardiopulmonary or faintness symptoms can be an emergency. New, persistent, after-sex, or postmenopausal bleeding needs clinical assessment. ACOG recommends endometrial sampling as a first-line test for abnormal uterine bleeding after age 45, and its April 2026 update recommends both transvaginal ultrasound and endometrial sampling at the initial evaluation of most postmenopausal bleeding.^[7]^[9]^[13]

Get emergency help when

You are changing pads or tampons every hour for more than two hours in a row and have chest pain, shortness of breath, lightheadedness, or dizziness^[7]
You are fainting, severely weak, or otherwise feel medically unstable
Pregnancy is possible and bleeding is accompanied by sudden severe abdominal or pelvic pain, shoulder pain, weakness, dizziness, or fainting^[27]

Arrange prompt in-person evaluation for

Persistent or recurrent heavy bleeding
Bleeding between periods
Bleeding after sex
New bleeding after a period of stability
Pelvic pressure, a mass sensation, or significant pain
Symptoms of anemia
Abnormal uterine bleeding at age 45 or older
Any bleeding after 12 months without a natural period

What a medication cannot rule out

Perimenopausal bleeding can come from hormone fluctuation. It can also come from fibroids, polyps, adenomyosis, pregnancy, cervical disease, endometrial hyperplasia, cancer, infection, a bleeding disorder, or another medication.

A progestin can suppress bleeding without identifying the cause. That is why the standalone NETA label ties its abnormal-bleeding indication to the absence of organic pathology.^[2]

Why online care may not be your first stop

Online menopause care can review history, reconcile medication, arrange some testing, and adjust a treatment plan. A virtual-only visit cannot physically perform a pelvic examination, transvaginal ultrasound, endometrial biopsy, or IUD insertion, and it cannot stabilize acute blood loss.

If the bleeding is new, heavy, persistent, or unevaluated, the right first step may be in person. We would rather lose a conversion than send you into the wrong kind of appointment.

What does norethindrone cost in 2026?

The exact cash price depends on the product, quantity, ZIP code, pharmacy, insurance, and coupon. The drug name alone is not enough: a 28-tablet contraceptive pack, 30 standalone 5 mg tablets, and 84 fixed-combination tablets are different price searches. Compare the precise active ingredients, strength, and quantity on your prescription.

Dated national coupon-page snapshot

These were the package-table figures displayed on the national GoodRx pages on August 28, 2026; the pages said their coupon prices were last updated August 27, 2026. They are not pharmacy quotes and can change without notice.^[20]^[21]^[22]

Product searched	Quantity shown by the price page	Displayed national coupon figure	What the figure does not include
Norethindrone 0.35 mg	Three 28-tablet packs	$24.00 total	Your ZIP, chosen pharmacy, insurance copay, or whether the coupon is accepted
Norethindrone acetate 5 mg	30 tablets	$22.72	A guaranteed local price or confirmation that your pharmacy accepts the coupon
Estradiol/NETA 1 mg/0.5 mg	Three 28-tablet packs	$56.46 total	A guaranteed local price, insurance coverage, or clinical suitability

The old temptation is to turn this into a “cheapest drug” verdict. Do not. These products do different jobs, GoodRx exposes different default quantities, and the lowest listed coupon can move by pharmacy and location.

GoodRx also displayed lower “as low as” headline figures and location-specific pharmacy prices on the same pages. We used the package tables because they expose the strength and quantity being compared instead of mixing different price modules. For a provider-level cost comparison, see online HRT cost in 2026.

Use this five-field price check instead:

1. Exact generic ingredients
2. Exact strength
3. Exact quantity
4. Your ZIP code and pharmacy
5. Insurance price and cash-coupon price, compared separately

Never switch a hormonal medication because a national coupon page showed a lower number. Price belongs after medication fit, not before it.

How long can you stay on norethindrone in perimenopause?

There is no one stopping date for every norethindrone product. The standalone 5 mg NETA leaflet directs postmenopausal women not to use that product and tells patients to discuss regularly whether treatment should continue. The practical safeguard is a defined review trigger — not automatic refills with no reassessment.^[2]

Ask for review when:

The original treatment goal has been reached or changed
Bleeding becomes new, heavier, persistent, or returns after stability
You may have reached menopause
Side effects become difficult to tolerate
Systemic estrogen is added, removed, or changed
Another medication or major risk factor changes
A refill is being renewed without a clear plan

Perimenopause does not announce its final day. Hormonal contraception can also make the final natural period difficult to identify. That is why “review this when I have gone 12 months without a natural period” is useful only when your clinician agrees that the bleeding history can be interpreted that way.^[10]

Put one question in your calendar:

“Is this still the right product for the job it is doing now?”

What are the alternatives to norethindrone?

The right alternative depends on the job. Pregnancy prevention, evaluated heavy bleeding, hot-flash treatment, local vaginal symptoms, and endometrial risk reduction are separate decisions. Replacing one hormone without naming the goal can create a second mismatch.

If your goal is…	Options a clinician may discuss	Key distinction
Prevent pregnancy	Other progestin-only contraceptives, combined hormonal contraception for eligible patients, implant, hormonal or copper IUD, barrier methods, permanent contraception	Only contraceptive products should be counted as contraception
Treat evaluated heavy menstrual bleeding	A 52 mg levonorgestrel IUS approved for heavy menstrual bleeding, tranexamic acid for cyclic heavy bleeding, other hormonal treatment, or treatment aimed at a fibroid, polyp, adenomyosis, or other cause	The cause, need for contraception, and eligibility change the choice
Treat hot flashes or night sweats	Systemic menopause hormone therapy when appropriate or FDA-approved nonhormonal options	Norethindrone alone has no FDA-labeled VMS indication
Reduce endometrial hyperplasia risk while using systemic estrogen	An FDA-approved fixed estrogen–progestogen product, FDA-approved micronized progesterone in its labeled context, or another clinician-directed regimen	Match the progestogen plan to the estrogen, uterus status, and evidence
Treat vaginal dryness or painful sex alone	Local vaginal estrogen, other approved local treatments, moisturizers, and lubricants	A systemic norethindrone-only product is not the default local treatment

Mirena and Liletta are 52 mg levonorgestrel intrauterine systems with FDA labeling for treatment of heavy menstrual bleeding for up to five years in patients who choose intrauterine contraception. Tranexamic acid tablets are FDA-approved for cyclic heavy menstrual bleeding in females of reproductive potential.^[23]^[24]^[25]

UK NICE guidance says to consider an LNG-IUS first for heavy menstrual bleeding when there is no identified pathology, fibroids are smaller than 3 cm without cavity distortion, or adenomyosis is suspected or diagnosed. That is UK guidance, not a U.S. protocol, and we label it accordingly.^[26]

The damaging admission: a virtual-only service cannot insert an IUD. If the goal points there, the next correct appointment is in person.

Can an online provider help with this?

Online care can be useful for medication identification, history review, a clinician-directed prescription change, and coordination of testing. It is not the right starting point for an emergency or for care that requires a pelvic examination, ultrasound, biopsy, or IUD insertion. The bleeding pattern decides the setting before the affiliate offer does.

What each care setting can actually do

Need	Virtual menopause visit	In-person gynecology or primary-care visit	Emergency department
Reconcile the exact medication and goal	Yes	Yes	Not the main purpose
Review side effects and discuss a prescription change	Yes, when clinically appropriate	Yes	Usually only if urgent
Order or coordinate labs	Often	Yes	Yes, when urgent
Perform a pelvic examination	No	Yes	Yes, when needed
Perform transvaginal ultrasound	No	On site or by referral	Yes, when urgently indicated
Perform endometrial sampling	No	Yes or by referral	Sometimes, depending on the emergency
Insert a levonorgestrel IUD	No	Yes	No
Stabilize acute heavy blood loss	No	Limited	Yes

Here is what it costs us to tell you this: the treatment path may lead away from telehealth entirely. That is not a failed conversion. It is the page doing its job.

The pivot is equally honest. If you already have a prescription, have no urgent bleeding pattern, and need someone to decide whether the formulation fits the goal, that is exactly the kind of question a live clinical visit can resolve.

Want the next step matched to your symptoms, uterus status, risk history, insurance situation, and state — with an in-person-care flag when needed?
→ Use Find My HRT Path

What we verified — and what we did not

This guide was built by comparing current U.S. product labels across six commonly confused norethindrone formulation families, then checking CDC contraceptive guidance, ACOG bleeding guidance, The Menopause Society's perimenopause guidance, FDA's 2026 hormone-labeling updates, and current price-page snapshots. It does not claim firsthand medication use or individual clinical review.

What we verified on August 28, 2026

Current U.S. labeling for norethindrone 0.35 mg
Current U.S. labeling for standalone norethindrone acetate 5 mg
Current U.S. labeling for oral estradiol/NETA combinations
Current U.S. labeling for CombiPatch
Current U.S. labeling for Jinteli and Junel Fe 24-type products
The three-hour missed-pill rule for traditional norethindrone POPs
The 1,176-woman endometrial-hyperplasia trial table
The 86% and 88% amenorrhea figures for fixed oral estradiol/NETA products
The standalone NETA label's limitation on concomitant estrogen use for postmenopausal endometrial protection
The NETA-to-ethinyl-estradiol pharmacokinetic statement
ACOG's age-45 sampling recommendation and 2026 postmenopausal-bleeding update
The first six products with FDA-approved 2026 menopause-label changes
The dated GoodRx national summary figures shown in the cost section

What we did not verify — and do not claim

The purpose of your prescription
The cause of your bleeding
Whether you are eligible for any particular hormone regimen
A safe milligram conversion between norethindrone, NETA, and micronized progesterone
A guaranteed local pharmacy price
That any telehealth provider carries a particular norethindrone formulation
That one product is universally safer, more natural, or better tolerated
That this page was medically reviewed by a clinician

The HRT Index Verification Standard

This page was produced under The HRT Index Verification Standard — the documented process by which The HRT Index reviews providers: read every published price, separate FDA-approved from compounded, verify state availability and insurance, and re-check on a fixed schedule, with top providers checked monthly and the full roster quarterly. On a medication page, we apply the same dated-verification discipline to labels, guidance, and commercial facts.

We evaluate providers on exactly five pillars, in this order: clinical legitimacy, care quality, medication fit, price transparency, and access. We do not invent numeric provider scores.

What will be rechecked

Element	Refresh cadence	Verification method
FDA/DailyMed labels	Quarterly and after a safety communication	Reopen the exact current label for each formulation family
FDA 2026 menopause-label rollout	Monthly while product labels are changing	FDA updated-labeling page plus each product label
CDC missed-pill guidance	Quarterly	Current U.S. Selected Practice Recommendations
ACOG bleeding guidance	Quarterly	Current ACOG clinical guidance and practice updates
GoodRx summary figures	Monthly if the cost section remains	Exact product, strength, quantity, and dated capture
Internal links and tool routing	Monthly	Crawl and manual destination check

Five questions to ask before your next refill

A useful refill conversation should confirm the product, the job, the expected result, and the review trigger. These five questions turn “Is norethindrone right?” into a decision your clinician can answer without guessing what you mean.

Copy these. Take them with you.

1. “What is the exact generic name, strength, and form of what I am taking?”
2. “Is the main goal contraception, treatment of bleeding, endometriosis, menopause symptom treatment, or endometrial risk reduction with estrogen?”
3. “Is this exact use FDA-approved or off-label, and what evidence supports the plan?”
4. “What bleeding pattern should I expect, and what exact threshold should make me call?”
5. “When do we reassess this, and what finding would make us change it?”

If hot flashes or night sweats are the main complaint, add a sixth:

“Is this medicine treating those symptoms, or is it doing a different job?”

Frequently asked questions

Is norethindrone HRT?

Not on its own. Norethindrone-only products have no listed estrogen active ingredient and no FDA indication for menopause vasomotor symptoms. Fixed products combining estradiol or ethinyl estradiol with norethindrone acetate are menopause hormone therapy. The complete label decides the category.^[1]^[2]^[3]^[4]^[5]

Is norethindrone 0.35 mg the mini-pill?

Yes. Norethindrone 0.35 mg is the traditional prescription progestin-only contraceptive pill. It is FDA-approved to prevent pregnancy and uses a product-specific three-hour missed-pill rule.^[1]^[11]

Is norethindrone acetate 5 mg birth control?

It is not FDA-approved as contraception. Its label lists secondary amenorrhea, endometriosis, and abnormal uterine bleeding caused by hormonal imbalance in the absence of organic pathology. If pregnancy prevention matters, ask for the contraceptive plan directly.^[2]

Does norethindrone contain estrogen?

Norethindrone-only and standalone NETA tablets list no estrogen active ingredient. Some fixed products add estradiol or ethinyl estradiol. NETA is also partly metabolized to ethinyl estradiol, but that does not reclassify the standalone product as an estrogen-containing medication or create a clinical dose conversion.^[18]

Will norethindrone stop my period completely?

It might suppress bleeding in some regimens, but no product guarantees it. The 86% and 88% amenorrhea figures apply to specific fixed oral estradiol/NETA products studied in postmenopausal women. Bleeding on the 0.35 mg mini-pill is less predictable.^[1]^[3]

Does norethindrone help hot flashes?

No norethindrone-only U.S. product has an FDA indication for hot flashes. Fixed estrogen–NETA products do, but they are separate estrogen-containing menopause therapies.^[1]^[2]^[3]^[4]^[5]

Is norethindrone the same as progesterone?

No. Norethindrone and NETA are synthetic progestins; micronized progesterone is a different prescription drug. Their roles can overlap, but their labels and doses cannot be converted milligram for milligram.^[2]^[14]

Is norethindrone “bioidentical”?

No. Norethindrone is a synthetic progestin. “Bioidentical” describes molecular structure; it does not prove that a product is safer, more effective, or the right fit. This page discusses FDA-approved products and does not blur them with compounded medications.

Can I take norethindrone with an estradiol patch?

A clinician may prescribe a progestogen with systemic estradiol for a woman with a uterus, and CombiPatch is an FDA-approved fixed estradiol/NETA patch. That does not mean any standalone norethindrone tablet can be paired interchangeably with any estradiol patch.^[2]^[4]

What if my 0.35 mg pill is more than three hours late?

CDC treats a traditional norethindrone POP as missed when it is more than three hours late. Take it as soon as possible, continue the daily pills, and use condoms or avoid sex until pills have been taken correctly for two consecutive days. Consider emergency contraception after unprotected sex and confirm the instructions for your exact product.^[11]

Can norethindrone cause continuous spotting?

Yes. Irregular, frequent, or prolonged bleeding can occur, especially with the 0.35 mg pill. Persistent bleeding should not be waved off indefinitely; pregnancy, adherence, interactions, and gynecologic causes may need evaluation.^[1]^[8]

Does norethindrone cause weight gain?

Weight change appears in labeling, but the labels do not support predicting a specific amount or claiming everyone gains. The 0.35 mg label calls androgenic effects including weight gain rare; the standalone NETA label lists increases and decreases among reported reactions.^[1]^[2]

Can I just stop taking it?

Do not change a prescription without the clinician managing it. This is especially important if you have a uterus and are taking systemic estrogen with a prescribed progestogen, because the endometrial-protection plan depends on both parts of the regimen.^[3]^[14]

Is norethindrone the same as norethisterone?

Yes. Norethisterone is the international name commonly used in the UK and other countries; norethindrone is the U.S. name. Norethindrone acetate and norethisterone acetate likewise refer to the same acetate form.

When should bleeding be evaluated urgently?

Use emergency care when bleeding meets ACOG's emergency pattern — changing pads or tampons every hour for more than two hours in a row with chest pain, shortness of breath, lightheadedness, or dizziness — or when you are fainting or medically unstable. Any bleeding after 12 months without a natural period needs prompt assessment.^[7]^[9]

Before you go

If you take one thing from this page, make it this:

You cannot evaluate “norethindrone” from the name alone. You can evaluate the specific product in your hand, the job it was chosen to do, and whether that job matches what you need.

Once those three things line up, the rest becomes much clearer: what the label supports, what it does not, what bleeding to expect, whether contraception is covered, what the price search should contain, and what question belongs at the next appointment.

And if it turns out you were given a tool for a job you did not need done, that is not a failure. It is a conversation you now know how to start.

Still not sure which HRT program is right for you? Take our free 60-second matching quiz.

→ Find My HRT Path

Get a personalized action plan based on your symptoms, whether you have a uterus, your medication route preference, your risk history, your insurance situation, and your state — plus a flag for when online care is not the right starting point.

The HRT Index is the independent decision resource for online menopause and HRT care for women. Educational research only — not medical advice, and not a substitute for care from your own clinician. We may earn a commission if you use some links on this page; see our affiliate disclosure. It never changes what we verify or what we publish.